Disclosure Panels Details Page
Central Nervous System Cancers Panel - Disclosures as of 11/17/2021
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Joachim Baehring MD | Bristol Myers Squibb | None | None | None | ✔ |
| Mary Anne Bergman | None | None | None | None | ✔ |
| Marian Birkeland PhD | None | None | None | None | - |
| Orin Bloch MD | BrainLab | None | Monteris Medical | None | ✔ |
| Steven Brem MD | None | None | None | None | ✔ |
| Nicholas Butowski MD | Amgen Inc. Bayer HealthCare Ipsen Jazz Pharmaceuticals Inc. Karyopharm Therapeutics Medicenna Novartis Pharmaceuticals Corporation |
AbbVie, Inc. Amgen Inc. Cordance |
None | None | ✔ |
| Donald Cannon MD | None | None | None | None | ✔ |
| Samuel Chao MD | Blue Earth Diagnostics | None | Varian Medical Systems, Inc. | None | ✔ |
| Milan Chheda MD | NeoImmuneTech Orbus Therapeutics |
None | None | Patent pending on use of Zika virus for the treatment of cancer | ✔ |
| Stephen Clark MD, PhD, MSCI | None | Epiphany Biosciences | None | None | - |
| Eileen Cucinotta | None | None | None | None | - |
| Susan Darlow PhD | None | None | None | None | ✔ |
| Andrew Fabiano MD | None | None | Medtronic, Inc. | Arbor Pharmaceuticals - Clincial Research Support as Part of VIGILANT study | - |
| Peter Forsyth MD | None | National Cancer Institute National Cancer Research Institute (NCRI) National Institutes of Health (NIH) Physical Sciences Oncology Network (PSON) |
Bayer HealthCare Boehringer Ingelheim GmbH Bristol Myers Squibb GSK |
None | ✔ |
| Pierre Giglio MD | Agios Biomimetix, JV, LLC Prelude |
None | None | None | ✔ |
| Kristina Gregory MSN, RN | None | None | None | None | ✔ |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | - |
| Jona Hattangadi-Gluth MD | None | None | None | None | ✔ |
| Anne Holbrook PharmD, BCOP | None | None | None | None | ✔ |
| Matthias Holdhoff MD, PhD | PAREXEL International Corporation | None | Pfizer Inc. | None | ✔ |
| Craig Horbinski MD, PhD | None | None | None | None | - |
| Madeline Joyce BSN, RN, OCN | None | None | None | None | - |
| Larry Junck MD | Orbus Therapeutics | None | None | None | - |
| Thomas Kaley MD | None | None | None | None | ✔ |
| Priya Kumthekar MD | AbbVie, Inc. AstraZeneca Pharmaceuticals LP DNAtrix Genentech, Inc. Karyopharm Therapeutics Orbus Therapeutics |
Affinia Angiochem Berg Oncology Biocept Brown and James Law Firm Celularity EnClear Janssen Pharmaceutica Products, LP Novocure Orbus Therapeutics SDP Oncology Sintetica |
None | None | ✔ |
| Jay Loeffler MD | Advanced Oncotherapy Mevion Corporation |
None | None | None | - |
| Maciej Mrugala MD, PhD, MPH | Arbor Pharmaceuticals | AstraZeneca Pharmaceuticals LP | None | None | - |
| John Murphy | None | None | None | None | - |
| Louis Nabors MD | Agios, Inc. GBM AGILE IN8Bio Karyopharm Therapeutics Oblato Orbus University of Pennsylvania |
None | None | None | ✔ |
| Seema Nagpal MD | Agios, Inc. Berg Health LLC Inovio Insightec PharmAbcine |
None | Biocept Novocure Seattle Genetics, Inc. |
None | ✔ |
| Phioanh Leia Nghiemphu MD | Bristol Myers Squibb Global Coalition for Adaptive Research Springworks |
None | None | None | ✔ |
| Ian Parney MD, PhD | Boston Scientific Corporation Merck & Co., Inc. |
AbbVie, Inc. | None | None | - |
| Toral Patel MD | Ben and Catherine Ivy Foundation CPRIT National Cancer Institute NINDS |
Medical Malpractice Consultant (Defense) | Elekta GT Medical Technologies, Inc |
ZIOPHARM Oncology, Inc. | ✔ |
| Katherine Peters MD, PhD, FAAN | AbbVie, Inc. Agios, Inc. Biomimetix Novocure |
Vivicitas | None | None | ✔ |
| Jana Portnow MD | None | None | None | None | - |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | - |
| Vinay Puduvalli MD | Bexion Pharma Karyopharm Therapeutics Newave Novocure Prelude ZIOPHARM Oncology, Inc. |
AbbVie, Inc. Bayer HealthCare Newave Novocure Orbus Therapeutics ZIOPHARM Oncology, Inc. |
None | Gilead Sciences, Inc.|Newave | ✔ |
| Ian Robins MD, PhD | None | None | None | None | ✔ |
| Jason Rockhill MD, PhD | None | Seattle Genetics, Inc. | None | None | ✔ |
| Chad Rusthoven MD | Merck & Co., Inc. Takeda Pharmaceuticals North America, Inc. |
None | None | None | - |
| Nicole Shonka MD | None | None | None | None | ✔ |
| Bettyanne Sunderland BSN, OCN | None | None | None | None | - |
| Lode Swinnen MBChB | AbbVie, Inc. | BeiGene EUSA Pharmacyclics |
None | Johns Hopkins University | - |
| Alva Weir MD | AstraZeneca Pharmaceuticals LP DTRM bipharma |
None | None | None | ✔ |
| Stephanie Weiss MD | None | None | None | AstraZeneca Pharmaceuticals LP |Regeneron Pharmaceuticals, Inc. | ✔ |
| Patrick Wen MD | None | Bayer HealthCare Black Diamond Chimerix Merck & Co., Inc. Mundiphrama Novartis Pharmaceuticals Corporation Novocure Nuvation Bio |
None | None | ✔ |
| Nicole Willmarth PhD | None | None | Novocure | None | ✔ |